about  exactus inc exdi home about about pioneering firsts in point of care technology at exactus inc were changing the game for pointofcare technology we are developing for commercialization pointofcare diagnostics for measuring proteolytic enzymes in the blood based on a novel proprietary detection platform we are designing products with the potential to deliver rapid actionable information to physicians in order to provide improved treatment decisions for patients better health outcomes and long term reduction in healthcare costs revolutionary technologies that address gaps in healthcare our scientific advances are working to put important health diagnostics into the hands of medical experts at the pointofcare our handheld pointofcare diagnostic tools will analyze a single drop of blood using our proprietary biosensor technology a transformational approach to measuring blood clotting activity the fibrilyzer™ is being designed to be an easy to use handheld detection unit that uses proprietary technology to employ a disposable assay test biosensor strip using only a drop of blood the device provides a readout of a patients fibrinolysis status in as little as  seconds this technology will give attending physicians unprecedented access to actionable data during procedures where changes in fibrinolytic status can change quickly and that require rapid therapeutic response the fibrilyzer™ is designed to be guide critical decisions about the treatment of patients during surgery trauma and other conditions where patients are at risk of hemorrhage view product making early intervention possible in cancer recurrence the matrilyzer™ is designed to be a mobile screening device that monitors collagenase levels over time using a smartphone app results of the test would automatically be telemetered to the patients electronic medical record alerting the attending oncologist of a change in the patients status which may necessitate a more thorough examination the matrilyzer would be is the only athome test for cancer recurrence of its kind view product experienced leadership our leadership team includes technical experts and business leaders with a proven track record of developing and launching new products in the life sciences industry management team board of directors get in touch at exactus inc we believe there are significant market opportunities for our medical devices in the us europe and throughout the world contact us with questions about our company our products and possible partnerships opportunities contact us email alerts stay informed and receive company updates straight to your inbox sign up today products  exactus inc exdi home products products products empowering physicians and guiding patient care at exactus inc we are developing products to make actionable patient data available to healthcare providers in a way that is unmatched we are addressing current healthcare gaps with our easytouse portable devices that dramatically reduce the time required to return analysis on patient blood and collagenase activity revolutionary technology in the palm of your hand our pointofcare diagnostic tools will use patented technology to analyze biometric markers in a single drop of blood revealing important insights into patient health when physicians need to make treatment decisions our technologies are designed to provide them with the timely health data they need fibrilyzer measuring fibrinolytic activity the fibrilyzer™ is being developed to provide a simple and affordable means to assess the fibrinolytic status of patients in a broad range of applications including surgery and trauma orthopedics heart and stroke and chronic coronary disease management we believe the fibrilyzer™ could provide the basis for improved management of patients who are atrisk of hemorrhage speeding treatment decisions and potentially improving patient outcomes and saving costs view product what is coagulation cascade once a patient suffers an injury and the blood coagulation clotting cascade begins first responders and physicians must make treatment decisions that ensure the physiological process maintains a delicate balance during the cascade conditions could change significantly in minutes and cause fatal hemorrhaging or clotting the ability for physicians to consider a patients updated fibrinolytic markers in  seconds at the bedside is a game changer learn more matrilyzer measuring collagenase activity the matrilyzer™ is being developed to detect the initial occurrence or the recurrence of cancer as an athome monitoring device or during routine office visits the appearance of elevated levels of collagenase the enzyme that degrades collagen have been proven to be an early hallmark of cancer for patients that have been previously treated for cancer specifically solid tumors if and when the tumor recurs is of paramount importance view product email alerts stay informed and receive company updates straight to your inbox sign up today exactus inc exdi immediate results for immediate needs exactus inc is developing for commercialization the firstofitskind handheld pointofcare poc diagnostic devices to analyze specific markers in the blood get to know us a first for immediate pointofcare results were developing the first handheld test to measure fibrinolytic activity and the first athome test to detect the onset of metastasis our devices can eliminate the need to send patient samples to a lab and wait for test results view our innovaative devices our team is the source of our success our team is determined to speed up the process in diagnostic reporting and is calling upon their years of experience to bring these devices to the operating room and the bedside management team board of directors expand your horizons are you passionate about making a difference in the world of diagnostic testing are you eager to create revolutionary testing technologies if so we’d like to get to know you join our team investor relations exactus inc symbol otcqb exdi price change volume day lowhigh  week lowhigh investor relations view sec filings investor relations  exactus inc exdi home investors investor relations investors investor relations latest news exactus inc to present at medtech strategist innovation summit apr   latest financial results q  quarter ended mar   pdf html q filing zip xls html xbrl latest k for fiscal year  download k sign up for email alerts be the first to receive breaking news sign up today stock information symbol otcqb exdi price change volume  week lowhigh day lowhigh company overview exactus is a publicly traded life science company based in richmond virginia that is developing for commercialization pointofcare poc diagnostics for measuring proteolytic enzymes in the blood we anticipate our lead product the fibrilyzer™ will provide a simple and affordable means to assess the fibrinolytic status of patients in a broad range of applications and that the use of the fibrilyzer™ could provide the basis for improved management of patients who are atrisk of hemorrhage speeding treatment decisions and potentially improving patient outcomes and saving money our second product candidate the matrilyzer™ may be used to detect the recurrence of cancer and can be used as an athome monitoring device or during routine office visits the appearance of elevated levels of collagenase the enzyme that degrades collagen have been proven to be an early hallmark of cancer the matrilyzer™ is expected to communicate directly with the attending oncologist via a smart phone application to ensure that i the tests are being used properly and ii when collagenase levels are elevated signaling the need for the patient to have a more thorough examination contact information transfer agent equity stock transfer  w th st new york ny  t  infoequitystockcom wwwequitystockcom email alerts stay informed and receive company updates straight to your inbox sign up today profile  exactus inc exdi home investors company information profile investors company information profile business description exactus is a publicly traded life science company based in richmond virginia that is developing for commercialization pointofcare poc diagnostics for measuring proteolytic enzymes in the blood we anticipate our lead product the fibrilyzer™ will provide a simple and affordable means to assess the fibrinolytic status of patients in a broad range of applications and that the use of the fibrilyzer™ could provide the basis for improved management of patients who are atrisk of hemorrhage speeding treatment decisions and potentially improving patient outcomes and saving money our second product candidate the matrilyzer™ may be used to detect the recurrence of cancer and can be used as an athome monitoring device or during routine office visits the appearance of elevated levels of collagenase the enzyme that degrades collagen have been proven to be an early hallmark of cancer the matrilyzer™ is expected to communicate directly with the attending oncologist via a smart phone application to ensure that i the tests are being used properly and ii when collagenase levels are elevated signaling the need for the patient to have a more thorough examination company info address  sadler rd suite  glen allen va  telephone  industry classifications sectorhealthcare industrymedical diagnostics  research naicsdiagnostic imaging centers  sicmedical laboratories  email alerts stay informed and receive company updates straight to your inbox sign up today exdi key statistics  exactus inc financial ratios  marketwatch x tweet share this bulletin get news bulletins by email bulletin ftse closes lower as uk tobacco stocks are routed » investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close exactus inc otc exdi go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus exactus inc market open  quotes are delayed by  min jul    am exdi quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high    week low  week high   company description exactus inc is a life science company which engages in developing and commercializing pointofcare poc diagnostics for measuring proteolytic enzymes in the blood based on a novel detection platform it operates under the fibrilyzer and matrilyzer trademarks the company was founded on january  exactus inc is a life science company which engages in developing and commercializing pointofcare poc diagnostics for measuring proteolytic enzymes in the blood based on a novel detection platform it operates under the fibrilyzer and matrilyzer trademarks the company was founded on january   and is headquartered in glen allen va valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr philip j young   chairman president  chief executive officer ms kelley a wendt   cfo treasurer  principal accounting officer dr james r erickson   chief business officer mr timothy ryan   director  executive vice president dr krassen dimitrov   director insider actions – purchase – sale  – number of transactions  newslatestcompanyusexdi marketwatch news on exdi no news currently available for exdi newsnonmarketwatchcompanyusexdi other news on exdi q exactus inc  am may    edgar online  edg  q k k exactus inc  am march    edgar online  edg  q k q exactus inc  pm nov    edgar online  edg  q k q exactus inc  pm aug    edgar online  edg  q k at a glance exactus inc  sadler rd suite  glen allen virginia  phone   industry precision products sector industrial goods fiscal yearend  view sec filings revenue na net income m employees  annual report for exdi newspressreleasecompanyusexdi press releases on exdi exactus inc selected to participate at cavendish global health impact forum  am may    accesswire exactus inc to present at medtech strategist innovation summit  pm april    accesswire exactus inc to present at bio ceo  investor conference  am feb    accesswire exactus inc announces the appointment of dr james erickson as chief business officer  pm dec    accesswire exactus inc to present at the th annual ld micro main event  am nov    accesswire log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pmattel shares down  in friday trading pexpedia stock price target raised to  from  at ubs paarons shares up  in friday trading pwhere healthcare reform goes after failure to repeal and replace obamacare psp  down  points or  at  pdow industrials down  points at  pbreakingnasdaq pares losses down  points at  pftse  closes sharply lower in tobaccoled stock rout phere’s how much you should spend on a yoga mat and why you should always use your own phow advisers can fight the ‘crisis of trust’ in financial services phow venezuela chaos could spark oil rally opec has failed to achieve pwhy mccain shot down obamacare repeal pchip stocks are cool again but reality is here pintel earnings have message for amd and nvidia ‘bring it on’ pamazon’s freespending ways hit earnings but don’t expect a shift to thrift pstarbucks’ teavana stores are the latest casualty at the mall pwagerebound story takes another hit after drab eci report pwhat is an ico ptrump’s sketch of new york city skyline auctioned off pwells fargo fda plan to lower nicotine could be opportunity for altria philip morris loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  exactus inc company profile  bloomberg feedback exactus inc public company company profile sector health care industry biotech  pharma subindustry biotech exactus inc operates as a life science company the company develops diagnostics measurement products exactus conducts its research in the united states corporate information address  sadler road suite  glen allen va  united states phone  fax  web url wwwexactusdxcom board members chairmanpresidentceo company phillip young exactus inc executive vice president company board members company from the web key executives phillip j young chairmanpresidentceo kelly a wendt cfotreasurer james r erickson chief business officer timothy ryan tim executive vice president sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft exactus inc to present at medtech strategist innovation summithomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets close in  hrs  minssp  dow  nasdaq todays chartsdont get blindsided by teslas shiny new model exactus inc to present at medtech strategist innovation summitaccesswireapril  reblogsharetweetsharerichmond va  accesswire  april    exactus inc exdi a life science company that is developing and commercializing ultrafast handheld pointofcare poc diagnostic tools powering informed patient management announced today that the company management will present at the medtech strategist innovation summit scheduled for april   at the shelbourne hotel in dublin ireland to learn more about the medtech strategist innovation summit please click hereevent medtech strategist innovation summit location the shelbourne hotel in dublin ireland date april   time  am dst  am edtexactus ceo philip young will deliver a formal presentation and discuss recent business highlights and updates management will also be available for oneonone meetings to arrange a meeting with management please contact tim ryan at tryanexactusinccom or robert haag at exdiirthcommunicationscomabout the medtech strategistthe medtech strategist is an information and investment conferences provider focused exclusively on the underserved medtech market it is led by managing partners and coeditorsinchief david cassak and stephen levin along with a seasoned editorial team the company launched the medtech strategist a publication broadly covering the most important topics and trends in medical devices today in september  featuring a wide range of editorial offerings  from interviews with industry leaders to stories on leading companies profiles of groundbreaking startups and analyses of dynamic clinical markets and technology trends  the medtech strategist explores how innovation plays out in all of its various forms  clinical technological business model marketplace and financing  in the global medical device arenaabout exactus incexactus is a publicly traded life science company based in richmond virginia that is developing and commercializing pointofcare poc diagnostics for measuring proteolytic enzymes in the blood we anticipate our lead product the fibrilyzer™ will provide a simple and affordable means to assess the fibrinolytic status of patients in a broad range of applications and that the use of the fibrilyzer™ could provide the basis for improved management of patients who are atrisk of hemorrhage speeding treatment decisions and potentially improving patient outcomes and saving moneyour second product candidate the matrilyzer™ may be used to detect the recurrence of cancer and can be used as an athome monitoring device or during routine office visits the appearance of elevated levels of collagenase the enzyme that degrades collagen have been proven to be an early hallmark of cancer the matrilyzer™ can communicate directly with the attending oncologist via a smart phone application to ensure that i the tests are being used properly and ii when collagenase levels are elevated signaling the need for the patient to have a more thorough examination for more information about exactus please visit our website at wwwexactusinccomforwardlooking statements this press release and any statements of representatives and partners of exactus inc the company related thereto contain or may contain among other things certain forwardlooking statements within the meaning of the private securities litigation reform act of  such forwardlooking statements involve significant risks and uncertainties such statements may include without limitation statements with respect to the companys plans objectives projections expectations and intentions and other statements identified by words such as projects may will could would should believes expects anticipates estimates intends plans potential or similar expressions these statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties including those detailed in the companys filings with the securities and exchange commission actual results including without limitation the actual timing for or actual results of the companys clinical trial described herein or the fdas review of such results may differ significantly from those set forth or implied in the forwardlooking statements these forwardlooking statements involve numerous risks and uncertainties that are subject to change based on various factors many of which are beyond the companys control the company undertakes no obligation to publicly update any forwardlooking statements whether as a result of new information future events or otherwise except as required by applicable lawread morefor more informationcompany contactsphilip j young president and ceo pyoungexactusinccomcorporate communications contacttim ryan evp tryanexactusinccom investor relations contactrobert haag managing director irth communications exdiirthcommunicationscom tel source exactus increblogsharetweetsharerecently viewedyour list is emptywhat to read nextjeff bezos’ brief stint as world’s richest human ends with amazon’s secondquarter whifftechcrunchthis will be in everyones household by banyan hillsponsoredwednesday apple rumors iphone  enters trial productioninvestorplacebristolmyers bmy q earnings beats estimateszacksopioid protest leads to change at drug wholesalerabc newsengineer finds pattern makes millions in stocksmoney morningsponsoredunder armour uaa to report q earnings what lies aheadzackstax cuts just got more likelyyahoo financethe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderzuckerberg wifes ambitious secret finally exposedunewzmesponsoredtodays charts dont get blindsided by teslas shiny new model yahoo financewhy apple is discontinuing these ipodsyahoo finance videostocks whiff as earnings and economic data pour inyahoo financediscover it  out of  avg by k customersdiscover cardsponsoredthe real reason overseas manufacturing is coming to americayahoo financetrump’s unwitting legacy could be universal health coverageyahoo financeanthony scaramucci boasted trump could sink foot golf putts the white house says it’s thomasw what a piece of work this boss bottomkisser is can you imagine the pudgy trump in basketball shortsjoin the conversation